Cargando…
Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun
Metastasis is the leading cause of human cancer deaths. Unfortunately, no approved drugs are available for anti-metastatic treatment. In our study, high-throughput sequencing-based high-throughput screening (HTS(2)) and a breast cancer lung metastasis (BCLM)-associated gene signature were combined t...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Higher Education Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338618/ https://www.ncbi.nlm.nih.gov/pubmed/29667003 http://dx.doi.org/10.1007/s13238-018-0533-8 |